Mufg Securities Emea PLC Abbott Laboratories Transaction History

Mufg Securities Emea PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $28.5 Million - $34.9 Million	-247,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $28 Million - $31 Million	-240,000 Reduced 49.28%	247,000 $29.2 Million
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $46.2 Million - $54.4 Million	437,000 Added 874.0%	487,000 $56.5 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $10.9 Million - $12.8 Million	-100,000 Reduced 66.67%	50,000 $5.99 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $11.6 Million - $12.6 Million	110,000 Added 275.0%	150,000 $16.4 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $3.67 Million - $4.45 Million	40,000 New	40,000 $4.35 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $8.36 Million - $9.47 Million	-127,559 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $2.77 Million - $3.34 Million	45,595 Added 55.63%	127,559 $9.36 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $5.64 Million - $6.23 Million	-98,036 Reduced 54.46%	81,964 $5 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $10.1 Million - $11.5 Million	180,000 New	180,000 $10.8 Million

3,238

1.31B

8.71M

8.03M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.